Literature DB >> 22022727

Circulating cytokine levels, Epstein-Barr viremia, and risk of acquired immunodeficiency syndrome-related non-Hodgkin lymphoma.

Charles S Rabkin1, Eric A Engels, Ola Landgren, Rob Schuurman, M Constanza Camargo, James J Goedert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22022727      PMCID： PMC3320652          DOI： 10.1002/ajh.22119

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  23 in total

Review 1.  Cancer biomarkers in HIV patients.

Authors:  Richard F Ambinder; Kishor Bhatia; Otoniel Martinez-Maza; Ronald Mitsuyasu
Journal:  Curr Opin HIV AIDS       Date:  2010-11       Impact factor: 4.283

2.  Interleukin-4 and interleukin-5 map to human chromosome 5 in a region encoding growth factors and receptors and are deleted in myeloid leukemias with a del(5q).

Authors:  M M Le Beau; R S Lemons; R Espinosa; R A Larson; N Arai; J D Rowley
Journal:  Blood       Date:  1989-02-15       Impact factor: 22.113

3.  Analysis of covariance and standardization as instances of prediction.

Authors:  P W Lane; J A Nelder
Journal:  Biometrics       Date:  1982-09       Impact factor: 2.571

4.  A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia.

Authors:  J J Goedert; C M Kessler; L M Aledort; R J Biggar; W A Andes; G C White; J E Drummond; K Vaidya; D L Mann; M E Eyster
Journal:  N Engl J Med       Date:  1989-10-26       Impact factor: 91.245

Review 5.  The molecular biology and functions of the granulocyte-macrophage colony-stimulating factors.

Authors:  D Metcalf
Journal:  Blood       Date:  1986-02       Impact factor: 22.113

6.  Isolation and characterization of a human interleukin cDNA clone, homologous to mouse B-cell stimulatory factor 1, that expresses B-cell- and T-cell-stimulating activities.

Authors:  T Yokota; T Otsuka; T Mosmann; J Banchereau; T DeFrance; D Blanchard; J E De Vries; F Lee; K Arai
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

7.  Identification of a coordinate regulator of interleukins 4, 13, and 5 by cross-species sequence comparisons.

Authors:  G G Loots; R M Locksley; C M Blankespoor; Z E Wang; W Miller; E M Rubin; K A Frazer
Journal:  Science       Date:  2000-04-07       Impact factor: 47.728

8.  Non-Hodgkin's B cell lymphoma in persons with acquired immunodeficiency syndrome is associated with increased serum levels of IL10, or the IL10 promoter -592 C/C genotype.

Authors:  Elizabeth Crabb Breen; W John Boscardin; Roger Detels; Lisa P Jacobson; Michael W Smith; Stephen J O'Brien; Joan S Chmiel; Charles R Rinaldo; Shenghan Lai; Otoniel Martínez-Maza
Journal:  Clin Immunol       Date:  2003-11       Impact factor: 3.969

9.  Determinants of retrovirus (HTLV-III) antibody and immunodeficiency conditions in homosexual men.

Authors:  J J Goedert; M G Sarngadharan; R J Biggar; S H Weiss; D M Winn; R J Grossman; M H Greene; A J Bodner; D L Mann; D M Strong
Journal:  Lancet       Date:  1984-09-29       Impact factor: 79.321

10.  Molecular cloning, nucleotide sequence, and expression of the gene encoding human eosinophil differentiation factor (interleukin 5).

Authors:  H D Campbell; W Q Tucker; Y Hort; M E Martinson; G Mayo; E J Clutterbuck; C J Sanderson; I G Young
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205
View more
  13 in total

1.  Human herpesvirus-encoded kinase induces B cell lymphomas in vivo.

Authors:  Penny M Anders; Nathan D Montgomery; Stephanie A Montgomery; Aadra P Bhatt; Dirk P Dittmer; Blossom Damania
Journal:  J Clin Invest       Date:  2018-05-07       Impact factor: 14.808

2.  Coxiella burnetii antibody seropositivity is not a risk factor for AIDS-related non-Hodgkin lymphoma.

Authors:  Halie K Miller; Loredana Santo; M Constanza Camargo; Cheryl A Winkler; James J Goedert; Gilbert J Kersh; Charles S Rabkin
Journal:  Blood       Date:  2017-04-10       Impact factor: 22.113

3.  Immune Activation: Contribution to AIDS-Associated Non-Hodgkin Lymphoma.

Authors:  Marta Epeldegui; Otoniel Martínez-Maza
Journal:  For Immunopathol Dis Therap       Date:  2015

4.  Increased levels of circulating cytokines with HIV-related immunosuppression.

Authors:  Fatma M Shebl; Kai Yu; Ola Landgren; James J Goedert; Charles S Rabkin
Journal:  AIDS Res Hum Retroviruses       Date:  2011-12-02       Impact factor: 2.205

5.  Pretreatment circulating serum cytokines associated with follicular and diffuse large B-cell lymphoma: a clinic-based case-control study.

Authors:  Bridget Charbonneau; Matthew J Maurer; Stephen M Ansell; Susan L Slager; Zachary S Fredericksen; Steven C Ziesmer; William R Macon; Thomas M Habermann; Thomas E Witzig; Brian K Link; James R Cerhan; Anne J Novak
Journal:  Cytokine       Date:  2012-09-23       Impact factor: 3.861

Review 6.  Assessment of pre-diagnosis biomarkers of immune activation and inflammation: insights on the etiology of lymphoma.

Authors:  Elena Vendrame; Otoniel Martínez-Maza
Journal:  J Proteome Res       Date:  2010-10-01       Impact factor: 4.466

7.  Serum biomarkers of immune activation and subsequent risk of non-hodgkin B-cell lymphoma among HIV-infected women.

Authors:  Shehnaz K Hussain; Nancy A Hessol; Alexandra M Levine; Elizabeth Crabb Breen; Kathryn Anastos; Mardge Cohen; Gypsyamber D'Souza; Deborah R Gustafson; Sylvia Silver; Otoniel Martínez-Maza
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-09-17       Impact factor: 4.254

8.  Serum levels of the chemokine CXCL13, genetic variation in CXCL13 and its receptor CXCR5, and HIV-associated non-hodgkin B-cell lymphoma risk.

Authors:  Shehnaz K Hussain; Weiming Zhu; Shen-Chih Chang; Elizabeth Crabb Breen; Elena Vendrame; Larry Magpantay; Dan Widney; Daniel Conn; Mary Sehl; Lisa P Jacobson; Jay H Bream; Steven Wolinsky; Charles R Rinaldo; Richard F Ambinder; Roger Detels; Zuo-Feng Zhang; Otoniel Martínez-Maza
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-12-18       Impact factor: 4.254

9.  Elevated soluble IL-2Rα, IL-8, and MIP-1β levels are associated with inferior outcome and are independent of MIPI score in patients with mantle cell lymphoma.

Authors:  Mohamad B Sonbol; Matthew J Maurer; Mary J Stenson; Cristine Allmer; Betsy R LaPlant; George J Weiner; William R Macon; James R Cerhan; Thomas E Witzig; Mamta Gupta
Journal:  Am J Hematol       Date:  2014-09-19       Impact factor: 10.047

10.  Host factors associated with serologic inflammatory markers assessed using multiplex assays.

Authors:  Heather S McKay; Jay H Bream; Joseph B Margolick; Otoniel Martínez-Maza; John P Phair; Charles R Rinaldo; Alison G Abraham; Lisa P Jacobson
Journal:  Cytokine       Date:  2016-06-10       Impact factor: 3.861
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.